News Release 

Clinical trials registrations for COVID-19 interventions given exaggerated attention

JAMA Network Open

Research News

What The Study Did: Clinical trial registrations for COVID-19 interventions that were highly publicized during the COVID-19 pandemic compared with treatments not comparably promoted were assessed in this study.

Authors: Nadir Yehya, M.D., M.S.C.E., of the Children's Hospital of Philadelphia, is the author.

To access the embargoed study: Visit our For The Media website at this link


Editor's Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.


Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.